Impact of high-risk features on disease-free survival (DFS) in patients (pts) with high-risk stage II colon cancer (CC) in ACHIEVE-2 trial as part of the IDEA collaboration.

Dai Manaka,Manabu Shiozawa,Masahito Kotaka,Makio Gamoh,Akio Shiomi,Akitaka Makiyama,Yoshinori Munemoto,Toshiki Rikiyama,Mutsumi Fukunaga,Takashi Ueki,Kohei Shitara,Hiroshi Shinkai,Nobuyuki Tanida,Eiji Oki,Kentaro Yamazaki,Eiji Sunami,Takeharu Yamanaka,Takayuki Yoshino,Atsushi Ohtsu,Yoshihiko Maehara

Impact of high-risk features on disease-free survival (DFS) in patients (pts) with high-risk stage II colon cancer (CC) in ACHIEVE-2 trial as part of the IDEA collaboration.

2020

4011Background: The IDEA collaboration for high-risk stage 2 colorectal cancer patients (pts) demonstrated that for CAPOX, 3 months was non-inferior to 6 months treatment, while for FOLFOX, 6 month...

Keywords:

Oncology
Stage ii colon cancer
in patient
disease free survival
Distributed File System
Internal medicine
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations